Article

Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease

2020-05-30

Abstract excerpt

Coronavirus disease 2019 (COVID-19) is characterized by a high incidence of acute respiratory failure. The underlying immunopathology of that failure and how it compares to other causes of severe respiratory distress, such as influenza virus infection, are not fully understood. Here we addressed this by developing a prospective observational cohort of COVID-19 and influenza subjects with varying degrees of disease...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fbd3c350-d5b6-5228-8b89-785d615d174d
DOI: 10.1101/2020.05.28.20115667

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe DiseaseDOI 10.1101/2020.05.28.20115667Read

Cell type-specific immune dysregulation in severely ill COVID-19 patientsSemantic proximity Read

Suppressive myeloid cells are a hallmark of severe COVID-19Semantic proximity Read

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patientsSemantic proximity Read

Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic LandscapeSemantic proximity Read

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19Semantic proximity Read

Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in bloodSemantic proximity Read

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected PatientsSemantic proximity Read

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data ReuseSemantic proximity Read

Differentially expressed immune response genes in COVID-19 patients based on disease severitySemantic proximity Read

Assessment of longitudinal changes in immune responses in critically ill adults with COVID-19Semantic proximity Read

A distinct innate immune signature marks progression from mild to severe COVID-19Semantic proximity Read

Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patientsSemantic proximity Read